Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated:  12/31/1969
New Bedford
mi
from
New Bedford, MA
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated: 12/31/1969
New Bedford
mi
from
New Bedford, MA
Click here to add this to my saved trials
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated:  12/31/1969
Flowood
mi
from
Flowood, MS
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated: 12/31/1969
Flowood
mi
from
Flowood, MS
Click here to add this to my saved trials
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated:  12/31/1969
Investigator Site - Las Vegas
mi
from
Las Vegas, NV
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated: 12/31/1969
Investigator Site - Las Vegas
mi
from
Las Vegas, NV
Click here to add this to my saved trials
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated:  12/31/1969
Berlin
mi
from
Berlin, NJ
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated: 12/31/1969
Berlin
mi
from
Berlin, NJ
Click here to add this to my saved trials
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated:  12/31/1969
Cedarhurst
mi
from
Cedarhurst, NY
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated: 12/31/1969
Cedarhurst
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated:  12/31/1969
New York
mi
from
New York, NY
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated: 12/31/1969
New York
mi
from
New York, NY
Click here to add this to my saved trials
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated:  12/31/1969
Canton
mi
from
Canton, OH
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated: 12/31/1969
Canton
mi
from
Canton, OH
Click here to add this to my saved trials
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated:  12/31/1969
Investigator Site - Cincinnati
mi
from
Cincinnati, OH
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated: 12/31/1969
Investigator Site - Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated:  12/31/1969
Dayton
mi
from
Dayton, OH
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated: 12/31/1969
Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated:  12/31/1969
Oklahoma City
mi
from
Oklahoma City, OK
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated: 12/31/1969
Oklahoma City
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated:  12/31/1969
Investigational Site - Charleston
mi
from
Charleston, SC
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated: 12/31/1969
Investigational Site - Charleston
mi
from
Charleston, SC
Click here to add this to my saved trials
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated:  12/31/1969
Investigator Site - Austin
mi
from
Austin, TX
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated: 12/31/1969
Investigator Site - Austin
mi
from
Austin, TX
Click here to add this to my saved trials
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated:  12/31/1969
Dallas
mi
from
Dallas, TX
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated: 12/31/1969
Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated:  12/31/1969
Investigator Site - Houston
mi
from
Houston, TX
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated: 12/31/1969
Investigator Site - Houston
mi
from
Houston, TX
Click here to add this to my saved trials
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated:  12/31/1969
Investigator Site - San Antonio
mi
from
San Antonio, TX
12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients
A 12-Week Open-Label Extension Study to Evaluate TNX-102 SL Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling
Updated: 12/31/1969
Investigator Site - San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Birmingham, AL
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Sherman Oaks, CA
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated:  12/31/1969
Clinical Research Site
mi
from
Miami, FL
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated: 12/31/1969
Clinical Research Site
mi
from
Miami, FL
Click here to add this to my saved trials
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Orange City, FL
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Orange City, FL
Click here to add this to my saved trials
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Joliet, IL
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Joliet, IL
Click here to add this to my saved trials
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Shreveport, LA
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Shreveport, LA
Click here to add this to my saved trials
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated:  12/31/1969
Clinical Study Site
mi
from
Saint Louis, MO
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated: 12/31/1969
Clinical Study Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Charlotte, NC
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
The Woodlands, TX
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Bothell, WA
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Bothell, WA
Click here to add this to my saved trials
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Barranquilla,
Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) Conducted Globally
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Barranquilla,
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Atria Clinical Research
mi
from
Little Rock, AR
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Atria Clinical Research
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
CITrials, Inc.
mi
from
Bellflower, CA
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
CITrials, Inc.
mi
from
Bellflower, CA
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Radiant Research
mi
from
Cerritos, CA
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Radiant Research
mi
from
Cerritos, CA
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Apostle Clinical Trials, Inc
mi
from
Long Beach, CA
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Apostle Clinical Trials, Inc
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
CNRI - San Diego, LLC
mi
from
San Diego, CA
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
CNRI - San Diego, LLC
mi
from
San Diego, CA
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Artemis Institute for Clinical Research
mi
from
San Diego, CA
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
CI Trials
mi
from
Santa Ana, CA
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
CI Trials
mi
from
Santa Ana, CA
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Network, INC
mi
from
Torrance, CA
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network, INC
mi
from
Torrance, CA
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Shreenath Clinical Service
mi
from
Yorba Linda, CA
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Shreenath Clinical Service
mi
from
Yorba Linda, CA
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Meridien Research, Inc.
mi
from
Maitland, FL
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Meridien Research, Inc.
mi
from
Maitland, FL
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
University of South Florida Board of Trustees
mi
from
Tampa, FL
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
University of South Florida Board of Trustees
mi
from
Tampa, FL
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
iResearch Atlanta LLC
mi
from
Decatur, GA
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
iResearch Atlanta LLC
mi
from
Decatur, GA
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Uptown Research Institute, Llc
mi
from
Chicago, IL
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Uptown Research Institute, Llc
mi
from
Chicago, IL
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Louisiana Clinical Research
mi
from
Shreveport, LA
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Louisiana Clinical Research
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
St. Charles Psychiatric Associates
mi
from
Saint Charles, MO
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
St. Charles Psychiatric Associates
mi
from
Saint Charles, MO
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
St. Louis Clinical Trials, LLC
mi
from
Saint Louis, MO
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
St. Louis Clinical Trials, LLC
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Hassman Research Institue LLC.
mi
from
Berlin, NJ
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Hassman Research Institue LLC.
mi
from
Berlin, NJ
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
mi
from
Jamaica, NY
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
mi
from
Jamaica, NY
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
InSite Clinical Research LLC
mi
from
DeSoto, TX
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
InSite Clinical Research LLC
mi
from
DeSoto, TX
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Research Centers of America
mi
from
Hollywood, FL
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Research Centers of America
mi
from
Hollywood, FL
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
South Florida Research Phase I-IV
mi
from
Miami Springs, FL
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
South Florida Research Phase I-IV
mi
from
Miami Springs, FL
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Neuropsychiatric Research
mi
from
Winfield, IL
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Neuropsychiatric Research
mi
from
Winfield, IL
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
Arch Clinical Trials, LLC
mi
from
Saint Louis, MO
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
Arch Clinical Trials, LLC
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated:  12/31/1969
New Hope Clinical Research
mi
from
Charlotte, NC
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Status: Enrolling
Updated: 12/31/1969
New Hope Clinical Research
mi
from
Charlotte, NC
Click here to add this to my saved trials